Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys
File(s)LongTermAndRecentTrends.pdf (4.25 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Background: Antihypertensive medicines are effective in reducing adverse cardiovascular events. Our aim was to compare hypertension awareness, treatment and control, and how they have changed over time, in high-income countries. Methods: We used data on 526,336 participants aged 40-79 years in 123 national health examination surveys from 1976 to 2017 in twelve high-income countries: Australia, Canada, Finland, Germany, Ireland, Italy, Japan, New Zealand, South Korea, Spain, the UK, and the USA. We calculated the percent of participants with hypertension – defined as systolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg or being on pharmacological treatment for hypertension – who were aware of their condition, who were treated, and whose hypertension was controlled (i.e. lower than 140/90 mmHg). Findings: Canada, South Korea, Australia and the UK have the lowest prevalence of hypertension, and Finland the highest. In the 1980s and early 1990s, treatment rates were at most 40% and control rates were below 25% in most countries and age-sex groups. Over time, hypertension awareness and treatment increased and control rate improved in all twelve countries, with South Korea and Germany experiencing the largest improvements. Most of the increase occurred in the 1990s and early-mid 2000s, having plateaued since in most countries.Canada, Germany, South Korea and the USA have the highest rates of awareness, treatment and control, while Finland, Ireland, Japan and Spain the lowest. Even in the best performing countries, treatment coverage was at most 80% and control rates were below 70%. Interpretation: Hypertension awareness, treatment and control have improved substantially in high-income countries since the 1980s and 1990s. However, control rates have plateaued in the past decade, at levels lower than those in high-quality hypertension programmes. There is substantial variation across countries in the rates of hypertension diagnosis, treatment and control.
Date Issued
2019-08-24
Date Acceptance
2019-04-29
Citation
Lancet, 2019, 394 (10199), pp.639-651
ISSN
0140-6736
Publisher
Elsevier
Start Page
639
End Page
651
Journal / Book Title
Lancet
Volume
394
Issue
10199
Copyright Statement
© 2019 The Author(s). Published by Elsevier Ltd. This an open access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license ( https://creativecommons.org/licenses/by/4.0/ ).
Sponsor
Wellcome Trust
Grant Number
101506/Z/13/Z
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
BLOOD-PRESSURE CONTROL
NUTRITION EXAMINATION SURVEY
PREVALENCE
GUIDELINES
HEALTH
CANADA
MEDICATION
BURDEN
ADULTS
Adult
Age Distribution
Aged
Antihypertensive Agents
Blood Pressure
Developed Countries
Female
Health Knowledge, Attitudes, Practice
Health Surveys
Humans
Hypertension
Male
Middle Aged
Prevalence
Sex Distribution
NCD Risk Factor Collaboration (NCD-RisC)
Humans
Hypertension
Antihypertensive Agents
Health Surveys
Prevalence
Health Knowledge, Attitudes, Practice
Age Distribution
Sex Distribution
Blood Pressure
Developed Countries
Adult
Aged
Middle Aged
Female
Male
General & Internal Medicine
11 Medical and Health Sciences
Publication Status
Published
Date Publish Online
2019-07-18